Project Grant R01HL183250
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $739K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85724, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded the University of North Carolina at Chapel Hill $166,248 on September 26, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research triangulating causal effects of sleep, inflammation, and cardiometabolic disease. The research will identify oxylipin biomarkers associated with sleep problems—including insomnia, sleep apnea, and short sleep duration—and their relationship to cardiometabolic disease. The study...
- The National Institutes of Health National Heart Lung and Blood Institute awarded Mayo Clinic Arizona $243,678 on December 21, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a multisite longitudinal study characterizing sleep health, sleep disorders, and cognitive functioning in heart transplant recipients. The study will enroll 30 adult heart transplant recipients who are at least six months post-transplant and obtain repeated measures at nine and twelve...
- The National Heart, Lung, and Blood Institute awarded the University of Arizona $140,400 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test the acceptability and feasibility of "Corazon en Tus Manos," a culturally tailored stress-reduction intervention designed to reduce cardiovascular disease risk among Mexican-origin adults with metabolic dysfunction-associated steatotic liver disease (MASLD). The project, led by Dr. Adriana...
- The National Institute for Minority Health and Health Disparities, a division of the Department of Health and Human Services National Institutes of Health, awarded the University of California Irvine $1,288,442 on June 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a randomized controlled trial of a culturally adapted sleep intervention for Asian Americans. The project tests ASLEEP (Asian American Sleep Empowerment Program), a five-week...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...
- Federal Project Grant Award Summary Arizona State University received a $974,377 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) awarded September 4, 2025, with completion targeted for August 31, 2029. The award supports development of a wireless biomarker sensing system utilizing multi-band reconfigurable intelligent surfaces (RIS) to non-invasively monitor cardio-respiratory signals and assess sleep...
- The National Heart Lung and Blood Institute awarded New York University School of Medicine $795,421 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sex-specific responses to obstructive sleep apnea therapies. The research examines how oxidative stress mediates cardiovascular harm from obstructive sleep apnea, with particular focus on sex differences in treatment response. The study tests N-acetylcysteine, an antioxidant precursor that...
- The National Heart, Lung, and Blood Institute awarded the University of Arizona $778,582 on August 15, 2026, to identify genetic variants that perturb gene regulatory responses to athero-protective and athero-prone hemodynamic waveforms in human endothelial cells. The award funds research under the Cardiovascular Diseases Research program (CFDA 93.837). The project investigates how natural genetic variation governs endothelial cell responses to hemodynamic shear stress from blood flow, with...
- The National Heart, Lung, and Blood Institute awarded the Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute, $261,716 on July 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot a doula-delivered cognitive behavioral therapy for insomnia (CBT-I) intervention for pregnant individuals experiencing prenatal sleep disturbances. The project addresses the gap between evidence-based CBT-I treatment efficacy...
- The National Heart, Lung, and Blood Institute awarded Seattle Children's Hospital $1,736,235 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sleep health and its relationship to childhood systemic lupus erythematosus (CSLE) symptoms within the sociocultural and neighborhood contexts of affected youth. The research examines associations between sleep health dimensions—including duration, efficiency, regularity, and daytime sleepiness—and CSLE...